创伤性脑损伤后肺损伤中神经递质的研究进展
创伤性脑损伤(TBI)是全球高发的严重中枢神经系统损伤疾病,每年导致大量患者健康受损和生活质量下降。肺损伤是TBI常见且危险的后果,显著升高患者死亡率,探寻TBI后肺损伤的病理生理机制和可行治疗靶点已成为临床诊治的重要需求。神经递质作为神经系统信号传递的基本化学物质,不仅调控TBI中的神经元活动和凋亡,还显著影响TBI后肺损伤的病理生理机制,其失衡与肺损伤的发生和进展密切相关。本文系统综述了TBI后肺损伤的临床特征和主要发病机制,重点阐述谷氨酸(Glu)、γ-氨基丁酸(GABA)、去甲肾上腺素(NE)、多巴胺(DA)和乙酰胆碱(ACh)等关键神经递质在TBI后肺损伤中的作用,考察其对炎症反应、血管通透性和肺循环功能的影响。文章还评估了针对各神经递质系统的靶向治疗策略(如受体拮抗剂、转运体抑制剂和神经递质类似物)的研究进展和潜在应用,旨在为阐明TBI后肺损伤的神经调控机制提供理论框架,并为开发新型治疗策略和改善患者预后奠定基础。
要点
- TBI后肺损伤是常见且危险的后果,显著升高患者死亡率,探寻其病理生理机制和可行治疗靶点是临床诊治的重要需求。
- 神经递质不仅调控TBI中的神经元活动和凋亡,还显著影响TBI后肺损伤的病理生理机制,其失衡与肺损伤的发生和进展密切相关。
- 综述重点阐述谷氨酸(Glu)、γ-氨基丁酸(GABA)、去甲肾上腺素(NE)、多巴胺(DA)和乙酰胆碱(ACh)在TBI后肺损伤中的作用。
- 上述神经递质影响炎症反应、血管通透性和肺循环功能,是TBI后肺损伤神经调控机制的关键环节。
- 综述评估了受体拮抗剂、转运体抑制剂和神经递质类似物等靶向治疗策略的研究进展和潜在应用,旨在为开发新型治疗策略提供依据。
研究设计与关键结果
- 本文为综述,系统回顾TBI后肺损伤的临床特征和主要发病机制,重点阐述谷氨酸(Glu)、γ-氨基丁酸(GABA)、去甲肾上腺素(NE)、多巴胺(DA)和乙酰胆碱(ACh)等关键神经递质在TBI后肺损伤中的作用。
- 综述考察上述神经递质对炎症反应、血管通透性和肺循环功能的影响。
- 综述评估针对各神经递质系统的靶向治疗策略(如受体拮抗剂、转运体抑制剂和神经递质类似物)的研究进展和潜在应用。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Traumatic brain injury (TBI), as a significant central nervous system damage disease with high frequency in the world, leads to a huge number of patients with impaired health and lower quality of life every year. Lung injury is a common and dangerous consequence, which dramatically raises the mortality of patients. Discovering the pathophysiology of lung injury after TBI and discovering viable therapeutic targets has become an important need for clinical diagnosis and therapy. Neurotransmitters, as the fundamental chemical agents of the nervous system for signal transmission, not only govern neuronal activity and apoptosis in TBI but also significantly influence the pathophysiological mechanisms of lung injury subsequent to TBI. The imbalance is intricately linked to the onset and progression of lung damage. This paper systematically reviews the clinical characteristics and predominant pathogenesis of lung injury following TBI, emphasizing the role of key neurotransmitters, including glutamate (Glu), γ-aminobutyric acid (GABA), norepinephrine (NE), dopamine (DA), and acetylcholine (ACh), in lung injury post-TBI. It examines their influence on inflammatory response, vascular permeability, and pulmonary circulation function. Additionally, the paper evaluates the research advancements and potential applications of targeted therapeutic strategies for various neurotransmitter systems, such as receptor antagonists, transporter inhibitors, and neurotransmitter analogues. This research aims to offer a theoretical framework for clarifying the neural regulatory mechanisms of lung injury following TBI and to establish a basis for the development of novel therapeutic strategies and enhancement of the prognosis of the patients.
参考来源
- Cao L, Zhang H, Yu J, et al. [Research progress of neurotransmitters in lung injury after traumatic brain injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41331896. doi:10.3760/cma.j.cn121430-20250430-00416
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。